We are live on ! Find out more
AURA icon

Aura Biosciences
AURA

59 hedge funds and large institutions have $334M invested in Aura Biosciences in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 12

44% more capital invested

Capital invested by funds: $233M → $334M (+$102M)

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

5.28% more ownership

Funds ownership: 66.32% → 71.6% (+5.3%)

4% more funds holding

Funds holding: 57 → 59 (+2)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more call options, than puts

Call options by funds: $12K | Put options by funds: $12K

Holders
59
Holders Change
+2
Holders Change %
+3.51%
% of All Funds
0.93%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
32
Reduced
12
Closed
5
Calls
$12K
Puts
$12K
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$7.89M
2
BlackRock
BlackRock
New York
+$5.78M
3
EAM
Eventide Asset Management
Massachusetts
+$4.38M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$4.38M
5
State Street
State Street
Massachusetts
+$1.12M

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$3.93M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$482K
3
Citadel Advisors
Citadel Advisors
Florida
-$445K
4
NCM
Nantahala Capital Management
Connecticut
-$429K
5
Millennium Management
Millennium Management
New York
-$290K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$112K -$67.2K -6,286 -41%
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$78.9K -$76.7K -7,171 -53%
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$47K +$27.2K +2,543 +192%
Legal & General Group
54
Legal & General Group
United Kingdom
$32.6K -$2.25K -210 -7%
AIP
55
Ameritas Investment Partners
Nebraska
$28K +$9.56K +894 +65%
AB
56
Amalgamated Bank
New York
$28K -$8.19K -766 -25%
TRCT
57
Tower Research Capital (TRC)
New York
$22.8K +$8.23K +770 +72%
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
$19.2K +$4.49K +420 +37%
Toronto Dominion Bank
59
Toronto Dominion Bank
Ontario, Canada
$1K +$898 +84 New
Millennium Management
60
Millennium Management
New York
– -$290K -31,281 Closed
SG Americas Securities
61
SG Americas Securities
New York
– -$104K -11,201 Closed
Susquehanna International Group
62
Susquehanna International Group
Pennsylvania
– -$96K -10,343 Closed
UBS Group
63
UBS Group
Switzerland
– -$5.06K -545 Closed
EI
64
Ellevest Inc
New York
– -$121 -13 Closed
1 2
3

AURA Hedge Fund Activity: Q2 2023 in Review

59 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q2 2023, worth a combined $334M — up 44% from $233M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AURA positions and 5 closed out — a net gain of 2 holders — while 32 added to existing stakes and 12 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $7.89M. The largest seller was Citigroup, cutting an estimated $3.93M.

  • 59 institutional investors held Aura Biosciences (AURA) as of Q2 2023, up from 57 in Q1 2023.
  • Funds reported $334M of Aura Biosciences stock for Q2 2023, up 44% quarter-over-quarter.
  • 7 funds opened new Aura Biosciences positions in Q2 2023 and 5 closed out, a net change of +2 holders.
  • The largest Aura Biosciences buyer in Q2 2023 was Goldman Sachs, an estimated $7.89M added.
  • The largest Aura Biosciences seller in Q2 2023 was Citigroup, an estimated $3.93M sold.

Based on aggregated 13F filings for Q2 2023.